跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
羅 力瑋
教授
醫學系內科學科
電子郵件
lwlo
vghtpe.gov
tw
網站
https://cv.nycu.edu.tw/?action=member&id=28
h-index
h10-index
h5-index
9770
引文
54
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
3730
引文
33
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
521
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2006
2026
每年研究成果
概覽
指紋
網路
研究成果
(420)
類似的個人檔案
(6)
指紋
查看啟用 Li-Wei Lo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Ablation
31%
Ablation Outcomes
7%
Ablation Therapy
6%
Arrhythmia
6%
Arrhythmogenic Right Ventricular Cardiomyopathy
9%
Arrhythmogenic Right Ventricular Dysplasia
7%
Atrial Arrhythmia
8%
Atrial Fibrillation
98%
Atrial Fibrillation Ablation
33%
Atrial Fibrillation Recurrence
16%
Atrial Substrate
19%
Atrial Tachycardia
7%
Atrium
6%
Catheter Ablation
67%
CHA2DS2-VASc Score
13%
Clinical Characteristics
6%
Clinical Outcomes
6%
Complex Fractionated Atrial Electrograms
6%
Confidence Interval
9%
Dominant Frequency
6%
Electrogram
10%
Electrophysiological Characteristics
11%
Endocardium
5%
Hazard Ratio
8%
Heart Failure
7%
Ischemic Stroke
6%
Left Atrial
12%
Left Atrium
14%
National Cohort Study
10%
Non-paroxysmal Atrial Fibrillation
10%
Non-pulmonary Vein Triggers
5%
Oral Anticoagulants
6%
Paroxysmal Atrial Fibrillation
29%
Persistent Atrial Fibrillation
14%
Pulmonary Vein
13%
Pulmonary Vein Isolation
23%
Radiofrequency Catheter Ablation
7%
Renal Denervation
6%
Right Atrium
6%
Right Ventricular Outflow Tract
6%
Risk of Ischemic Stroke
6%
Sinus Rhythm
11%
Stroke Risk
5%
Structural Remodeling
5%
Substrate Properties
9%
Sudden Cardiac Death
6%
Superior Vena Cava
6%
Taiwan
7%
Ventricular Arrhythmia
26%
Ventricular Tachycardia
10%
Medicine and Dentistry
Ablation
71%
Ablation Therapy
8%
Antithrombotic
8%
Apoplexy
13%
Arrhythmogenic Right Ventricular Dysplasia
13%
Atrial Electrogram
6%
Atrial Fibrillation
100%
Atrial Fibrillation Ablation
11%
Atrial Flutter
9%
Atrium
5%
Brain Ischemia
6%
Cardiac Dysrhythmia
7%
Cardiovascular System
8%
CHA2DS2-VASc Score
10%
Cohort Analysis
11%
Congestive Heart Failure
10%
Electrocardiogram
7%
Electrography
15%
Endocardium
6%
Hazard Ratio
8%
Heart Atrium Arrhythmia
5%
Heart Ventricle Arrhythmia
18%
Left Atrium
13%
Myocardial Disease
7%
Paroxysmal Atrial Fibrillation
27%
Persistent Atrial Fibrillation
11%
Premature Ventricular Contraction
6%
Pulmonary Vein
18%
Pulmonary Vein Isolation
22%
Recurrent Disease
31%
Risk Stratification
5%
Sinus Rhythm
9%
Sudden Cardiac Death
6%
Superior Vena Cava
5%
Supraventricular Tachycardia
9%
Tachyarrhythmia
5%
Ventricular Outflow Tract
9%
Ventricular Tachycardia
20%
